ICD-10 Code C93.12 | Chronic myelomonocytic leukemia, in relapse Symptoms, Diagnosis, Billing

Chronic myelomonocytic leukemia (CMML) is a type of cancer that affects the blood and bone marrow, characterized by the proliferation of monocytes and myeloid cells. When classified as 'in relapse,' it indicates a return of the disease after a period of remission. Accurate coding with ICD-10 Code C93.12 is essential for proper diagnosis, documentation, medical billing, and public health reporting, ensuring that healthcare providers can effectively track and manage this complex condition.

What is ICD-10 Code C93.12 for Chronic myelomonocytic leukemia, in relapse?

ICD-10 Code C93.12 specifically denotes Chronic myelomonocytic leukemia that is currently in relapse. This condition arises from the uncontrolled growth of monocytes, leading to various complications. The code should be utilized in clinical documentation and billing when a patient presents with a recurrence of symptoms after a period of remission, ensuring accurate representation of the patient's health status.

ICD-10 Code C93.12 – Clinical Definition and Explanation of Chronic myelomonocytic leukemia, in relapse

Chronic myelomonocytic leukemia, in relapse, is a hematological malignancy that typically arises from mutations in hematopoietic stem cells, leading to an overproduction of monocytes. The condition can progress to severe complications, including infections and organ dysfunction, necessitating prompt medical intervention.

Key Clinical Features:

• Elevated monocyte counts in peripheral blood.
• Symptoms may include fatigue, fever, and splenomegaly.
• Potential for transformation into acute myeloid leukemia.
• Increased risk of infections due to immunosuppression.

ICD-10 Code C93.12 for Chronic myelomonocytic leukemia, in relapse – SOAP Notes & Clinical Use

ICD-10 Code C93.12 is utilized in SOAP notes to document the patient's symptoms, assessment findings, and treatment plans. It plays a critical role in both acute and chronic care settings, ensuring that the patient's condition is accurately recorded and managed throughout their healthcare journey.

What Does ICD-10 Code C93.12 for Chronic myelomonocytic leukemia, in relapse Mean in SOAP Notes?

In SOAP notes, ICD-10 Code C93.12 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of Chronic myelomonocytic leukemia in relapse. This ensures continuity of care, supports accurate billing, and meets EHR documentation standards.

Treatment Options for ICD-10 Code C93.12 – Chronic myelomonocytic leukemia, in relapse

The management of Chronic myelomonocytic leukemia in relapse often requires hospitalization for intensive treatment and monitoring.

Antibiotic Therapy:

• Ciprofloxacin 500 mg orally twice daily for 7-14 days.
• Piperacillin-tazobactam 3.375 g IV every 6 hours for 7-14 days.
• Vancomycin 1 g IV every 12 hours for 7-14 days.

Supportive Care:

• Transfusion support for anemia and thrombocytopenia.
• Growth factor support (e.g., G-CSF) to stimulate bone marrow recovery.
• Pain management and palliative care as needed.

Infection Control:

• Strict hand hygiene protocols to prevent nosocomial infections.
• Isolation precautions for neutropenic patients.
• Monitoring for signs of infection and prompt intervention.

How to Document Symptoms of Chronic myelomonocytic leukemia, in relapse (ICD-10 C93.12) in SOAP Notes

Subjective:

• Patient reports increased fatigue and weakness.
• History of recurrent fevers and night sweats.
• Complaints of abdominal discomfort due to splenomegaly.
• Previous remission period of 6 months before relapse.

Objective:

• CBC shows elevated monocyte count of 15,000 cells/µL.
• Physical exam reveals splenomegaly and pallor.
• Vital signs: temperature 101°F, heart rate 95 bpm.
• Bone marrow biopsy confirms relapse of CMML.

Secure, compliant, and built for trust

HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.

Learn more

SOAP Note Guidelines for Diagnosing Chronic myelomonocytic leukemia, in relapse (ICD-10 Code C93.12)

Assessment:

• Diagnosis: Chronic myelomonocytic leukemia, in relapse (ICD-10 C93.12).
• Severity: Moderate to severe based on clinical presentation.
• Contributing factors: Previous treatment history and current symptoms.
• Risk of complications due to immunosuppression.

Plan:

• Initiate chemotherapy regimen as per oncology protocol.
• Schedule regular CBC monitoring to assess blood counts.
• Educate patient on signs of infection and when to seek care.
• Plan for follow-up appointment in 2 weeks to reassess.

Treatment & Plan Section for ICD-10 Code C93.12 – Chronic myelomonocytic leukemia, in relapse

• First-line pharmacologic treatments include cytarabine and azacitidine.
• Non-pharmacologic strategies involve nutritional support and psychological counseling.
• Monitoring practices include regular blood tests and imaging studies.
• Follow-up should be scheduled every 1-2 weeks during treatment.

Using ICD-10 Code C93.12 for Chronic myelomonocytic leukemia, in relapse in Billing & SOAP Note Compliance

• Select appropriate documentation to support the diagnosis in SOAP notes.
• Ensure accurate coding reflects the patient's current clinical status.
• Align treatment plans with established clinical guidelines for billing.
• Use CPT codes that correspond to the services provided for justified billing.

Related ICD-10 Codes Often Used with Chronic myelomonocytic leukemia, in relapse

• C93.11 – Chronic myelomonocytic leukemia, not in relapse
• C92.10 – Acute myeloid leukemia, not otherwise specified
• C92.30 – Acute myeloid leukemia with myelodysplastic features

ICD-10 Code C93.12 in Medical Billing and Insurance for Chronic myelomonocytic leukemia, in relapse

ICD-10 Code C93.12 is crucial for accurate billing in hospital, ER, or infectious disease care settings.

Billing Notes:

• Document all relevant clinical findings to support the diagnosis.
• Use this code in conjunction with treatment codes for comprehensive billing.
• Ensure that the patient's medical history is clearly outlined in the chart.
• Review coding guidelines regularly to maintain compliance.

Common CPT Pairings: